Stryker Corp
XMUN:SYK
Stryker Corp
XMUN:SYK
Price:
300.15
EUR
-2.96%
Market Cap:
€114.9B
Relative Value
The Relative Value of one
SYK
stock under the Base Case scenario is
277.42
EUR.
Compared to the current market price of 300.15 EUR,
Stryker Corp
is
Overvalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SYK
Relative Value
Base Case
277.42
EUR
Overvaluation 8%
Multiples Across Competitors
SYK Competitors Multiples
Stryker Corp Competitors
Stryker Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Stryker Corp
XMUN:SYK
|
128.8B EUR | 5.1 | 39.7 | 20.3 | 24.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.6B USD | 4.2 | 28.8 | 16.5 | 22.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.7B USD | 16.7 | 58.7 | 44.5 | 54.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD | 5.1 | 35.4 | 20.8 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.2B EUR | 1.9 | 20.5 | 11.4 | 16.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.5B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.4B USD | 2.1 | 25.8 | 10.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.2 | 30.6 | 33.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.3B USD | 1.6 | 15.5 | 11.2 | 13.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
